Get started
Intercept Pharmaceuticals, Inc. 2.0% 15-MAY-2026Intercept Pharmaceuticals, Inc. 2.0% 15-MAY-2026Intercept Pharmaceuticals, Inc. 2.0% 15-MAY-2026

Intercept Pharmaceuticals, Inc. 2.0% 15-MAY-2026

No trades
See on Supercharts
Overview
Analysis

ICPT4833277 chart


Full chart

Key terms


Outstanding amount
‪26.00 K‬ USD
Face value
1,000.00 USD
Minimum denomination
1,000.00 USD
Coupon
2.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
2.14%
Maturity date
May 15, 2026
Term to maturity
1 year

About Intercept Pharmaceuticals, Inc. 2.0% 15-MAY-2026


Issuer
Intercept Pharmaceuticals, Inc.
Sector
Health Technology
Home page
interceptpharma.com
Issue date
May 14, 2019
FIGI
BBG00P4GND55
Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.

ICPT4833277 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.